Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
34.10
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $4.28 billion as of September 4, 2026. Its market cap has increased by 387.80% in one year.
Market Cap
4.28B
Enterprise Value
4.03B
1-Year Change
387.80%
Ranking
Category
Stock Price
$34.10
ChartMarket Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $4.28B, an increase of 300.30%. That is a compound annual growth rate of 34.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.28B | 222.62% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantheus Holdings | 6.59B |
| Hims & Hers Health | 6.47B |
| Liquidia | 6.15B |
| Kiniksa Pharmaceuticals International, | 6.08B |
| Amneal Pharmaceuticals | 6.07B |
| Indivior Pharmaceuticals | 4.12B |
| Regencell Bioscience Holdings | 3.41B |
| BioCryst Pharmaceuticals | 2.55B |